Delivery Order SPE2DB22D3004-SPE2DB24FPG03
Award Date 2/7/24
Potential Completion Date 2/29/24
Potential Value $7.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product IBRANCE 125 MG TABLET 7S, with a completion date of March 5, 2024 and a potential value of $7,792.08. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this order, which is not designated as a set-aside. The company...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, has been awarded a $15,595.70 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IBRANCE 75 MG CAPSULE 21S, a pharmaceutical product. The contract has a completion date of March 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,797.84 award is for the supply of the pharmaceutical product IBRANCE 75 MG TABLET 7S. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves...
- This is a $8,122.48 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, with a period of performance ending on June 9, 2025. The award was made on May 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,797.84 firm fixed-price delivery order is for the supply of 4565333853 - IBRANCE 75 MG TABLET 7S, a prescription medication. The contract has an ultimate completion date of August 23, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $7,796.30 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for the supply of IBRANCE 100 MG TABLET 7S, a prescription medication. The order has an ultimate completion date of August 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, to provide a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceuticals, specifically the drug IBRANCE 100 MG TABLET 7S, with a ceiling value of $7,796.30 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a Firm Fixed Price Delivery Order contract (SPE2DX15D3404|SPE2DX24F1ASP) by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The $7,792.08 contract is for the delivery of Ibrance 125 mg Capsule 21s, a pharmaceutical product. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and DLA, which serves as the...
- This is a firm fixed price delivery order (SPE2DX15D3013|SPE2DX24FH4B0) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $7,796.30 award is for the delivery of 4564073591 IBRANCE 100 MG TABLET 7S, a pharmaceutical product, with a performance period through April 15, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this order, which does not have a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ibrance 125 mg tablets in a 7-tablet configuration. This contract, valued at $8,118.08 with a firm fixed price structure, represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 12, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPG03Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,792.08 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide IBRANCE 125 MG TABLET 7S pharmaceutical products. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA to deliver a comprehensive range of medications and medical supplies to military treatment programs and facilities worldwide. The IDC has a potential value of $999,999,999.00 and a period of performance through December 31, 2025. This award does not have a set-aside designation.
Generated 5/8/24, 9:40 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 2/7/24 |